Center Laboratories's latest marketcap:
As of 04/30/2026, Center Laboratories's market capitalization has reached $921.38 M. According to our data, Center Laboratories is the 11290th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 921.38 M |
| Revenue (ttm) | 47.98 M |
| Net Income (ttm) | 295.04 M |
| Shares Out | 746.53 M |
| EPS (ttm) | 0.36 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 10/03/2025 |
| Earnings Date | 04/02/2026 |
Center Laboratories's yearly market capitalization.
| Date | Market Cap(NT$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/01/2026 | NT$28.67 B | $915.85 M | -7.69% | n/a |
| 12/31/2025 | NT$31.06 B | $989.16 M | -1.69% | 9726 |
| 12/31/2024 | NT$31.59 B | $961.93 M | 3.14% | 9014 |
| 12/29/2023 | NT$30.63 B | $996.39 M | 8.88% | 8673 |
| 12/30/2022 | NT$28.13 B | $918.51 M | -7.93% | 8703 |
| 12/30/2021 | NT$30.56 B | $1.1 B | -3.72% | 8837 |
| 12/31/2020 | NT$31.74 B | $0 | 30.27% | 7436 |
| 12/31/2019 | NT$24.36 B | $813.22 M | 4.2% | 7728 |
| 12/28/2018 | NT$23.38 B | $763.59 M | 51.97% | 7138 |
| 12/29/2017 | NT$15.39 B | $517.71 M | -13.34% | 10257 |
Company Profile
About Center Laboratories, Inc.
Center Laboratories, Inc. is a pharmaceutical company specializing in the development, manufacturing, and sale of pharmaceuticals. Headquartered in Taipei City, Taiwan, the company has been serving both domestic and international markets since its founding in 1959.
Product Offerings
The company provides a diverse range of pharmaceutical products, including:
- General Medication: Antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agents, expectorants, narcotic and non-narcotic antitussives, gastrointestinal preparations, and other medicines.
- Central Nervous System Medication: Treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease.
- Diabetes Care: Solutions for diabetes and pancreatic beta cell treatment.
Business Segments
Beyond pharmaceuticals, Center Laboratories, Inc. is involved in:
- Drug development
- Cell therapy
- Biotechnology and biopharmaceuticals
- Hydrogen energy
- Dairy business
Frequently Asked Questions
-
What is Center Laboratories's (TPEX-4123) current market cap?As of 04/30/2026, Center Laboratories (including the parent company, if applicable) has an estimated market capitalization of $921.38 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Center Laboratories (TPEX-4123) rank globally by market cap?Center Laboratories global market capitalization ranking is approximately 11290 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.